Toxoplasma gondii: The role of IFN-gamma, TNFRp55 and iNOS in inflammatory changes during infection

Experimental Parasitology

Volumn 123, Issue 1, 2009, Pages 65-72

  Silva, Neide Maria ^a   Vieira, Júlio César Menezes ^b   Carneiro, Claudia Martins ^c   Tafuri, Wagner Luiz ^b  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

IFN ; Inflammation; iNOS; Protozoa; TNFRp55; Toxoplasma gondii

Indexed keywords

GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR RECEPTOR;

ACUTE PHASE RESPONSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HISTOLOGY; HOST PATHOGEN INTERACTION; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; INFLAMMATION; MORTALITY; MOUSE; NONHUMAN; PARASITISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; BRAIN; HEART; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERFERON-GAMMA; LIVER; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SPINAL CORD; SPLEEN; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; TUMOR NECROSIS FACTOR DECOY RECEPTORS;

ANIMALIA; MUS; PROTOZOA; TOXOPLASMA GONDII;

EID: 67949094220     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2009.05.011     Document Type: Article

References (53)

1. Adams L.B., Hibbs Jr. J.B., Taintor R.R., and Krahenbuhl J.L. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from l-arginine. The Journal of Immunology 144 (1990) 2725-2729
2. Benjamim C.F., Silva J.S., Fortes Z.B., Oliveira M.A., Ferreira S.H., and Cunha F.Q. Inhibition of leukocyte rolling by nitric oxide during sepsis leads to reduce migration of active microbial neutrophils. Infection and Immunity 70 (2002) 3602-3610
3. Benevides L., Milanezi C.M., Yamauchi L.M., Benjamim C.F., Silva J.S., and Silva N.M. CCR2 receptor is essential to activate microbicidal mechanisms to control Toxoplasma gondii infection in the central nervous system. The American Journal of Pathology 173 (2008) 741-751
4. Bennouna S., Bliss S.K., Curiel T.J., and Denkers E.Y. Cross-talk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells during microbial infection. The Journal of Immunology 171 (2003) 6052-6058
5. Bernardes E.S., Silva N.M., Ruas L.P., Mineo J.R., Loyola A.M., Hsu D.K., Chammas R., and Roque-Barreira M.C. Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptative immunity. The American Journal of Pathology 168 (2006) 1910-1920
6. Bliss S.K., Gavrilescu L.C., Alcaraz A., and Denkers E.Y. Neutrophil depletion during Toxoplasma gondii infection leads to impaired immunity and lethal systemic pathology. Infection and Immunity 69 (2001) 4898-4905
7. Candolfi E., Hunter C.A., and Remington J.S. Roles of gamma interferon and other cytokines in suppression of the spleen cell proliferative response to concanavalin A and Toxoplasma antigen during acute toxoplasmosis. Infection and Immunity 63 (1995) 751-756
8. Dalton D.K., Haynes L., Chu C.-Q., Swain S.L., and Wittmer S. Interferon γ eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. The Journal of Experimental Medicine 192 (2000) 117-122
9. DeCaterina R., Libby P., Peng H.-B., Thannickal V.J., Rajavashisth Jr. T.B., Gimbrone M.A., Shin W.S., and Liao J.K. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. The Journal of Clinical Investigation 96 (1995) 60-68
10. Deckert-Schluter M., Bluethmann H., Rang A., Hof H., and Schluter D. Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis. The Journal of Immunology 160 (1998) 3427-3436
11. Deckert-Schluter M., Rang A., Weiner D., Huang S., Wiestler O.D., Hof H., and Schluter D. Interferon-γ receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation. Laboratory Investigation 75 (1996) 827-841
12. Denkers E.Y., Butcher B.A., Del Rio L., and Bennouna S. Neutrophils, dendritic cells and toxoplasma. The International Journal of Parasitology 34 (2004) 411-421
13. Denkers E.Y. T lymphocyte-dependent effector mechanisms of immunity to Toxoplasma gondii. Microbes and Infection 1 (1999) 699-708
14. Denkers E.Y., and Gazzinelli R.T. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clinical Microbiology Review 11 (1998) 69-230
15. Dunay I.R., Damatta R.A., Fux B., Presti R., Greco S., Colonna M., and Sibley L.D. Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity 29 (2008) 306-317
16. Echtenacher B., Falk W., Mannel D.N., and Krammer P.H. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. The Journal of Immunology 145 (1990) 3762-3766
17. Eskandari M.K., Bologos G., Miller C., Nguyen D.T., DeForges L.E., and Remick D.G. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture and endotoxemia. The Journal of Immunology 148 (1992) 2724-2730
18. Frenkel J.K. Pathophysiology of toxoplasmosis. Parasitology Today 4 (1988) 273-278
19. Gaboury J.P., Xiao-Fei N., and Kubes P. Nitric oxide inhibits numerous features of mast cell-induced inflammation. Circulation 93 (1996) 318-326
20. Gauthier T.W., Davenpeck K.L., and Lefer A.M. Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in sphanchnic ischemia-reperfusion. American Journal of Physiology 267 (1994) G562-G568
21. + T cells and accompanied by overproduction of IL-12, IFN-γ, and TNF-α. The Journal of Immunology 157 (1996) 798-805
22. Gazzinelli R.T., Eltoum I., Wynn T.A., and Sher A. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF- and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. The Journal of Immunology 151 (1993) 3672-3681
23. + T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. The Journal of Immunology 149 (1992) 175-180
24. Gazzinelli R.T., Hakim F.T., Hieny S., Shearer G., and Sher A. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN- production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. The Journal of Immunology 146 (1991) 286-292
25. Hasty K.A., Pourmotabbed T.F., Goldberg G.I., Thompson J.P., Spinella D.G., Stevens R.M., and Mainardi C.L. Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. The Journal of Biological Chemistry 265 (1990) 11421-11424
26. Hayashi S., Chan C.C., Gazzinelli R.T., and Roberge G. Contribution of nitric oxide to the host parasite equilibrium in toxoplasmosis. The Journal of Immunology 156 (1996) 1476-1481
27. Hickey M.J., Sharkey K.A., Sihota E.G., Reinhardt P.H., Macmicking J.D., Nathan C., and Kubes P. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. The FASEB Journal 11 (1997) 955-964
28. Hunter C.A., Ellis-Neyes L.A., Slifer T., Kanaly S., Crünig G., Fort M., Rennick D., and Araujo F.G. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. The Journal of Immunology 158 (1997) 3311-3316
29. Kasper L.H., and Buzoni-Gatel D. Some opportunistic parasitic infections in AIDS: candidiasis, pneumocystosis, cryptosporidiosis, toxoplasmosis. Parasitology Today 14 (1998) 150-156
30. Khan I.A., Schwartzman J.D., Matsuura T., and Kasper L.H. A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. Proceedings of the National Academy of Sciences 94 (1997) 13955-13960
31. Khan B.V., Harrison D.G., Olbrych M.T., Alexander R.W., and Medford R.M. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proceedings of the National Academy of Sciences 93 (1996) 9114-9119
32. Khan I.A., Matsuura T., and Kasper L.H. IL-10 mediates immunosuppression following primary infection with Toxoplasma gondii in mice. Parasite Immunology 17 (1995) 185-195
33. Langermans J.A.M., Van Der Hulst M.E.B., Nibbering P.H., Hiemstra P.S., Fransen L., and Van Furth R. IFN- induced l-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-α. The Journal of Immunology 148 (1992) 568-574
34. Lee A.H., Hong J.-H., and Seo Y.-S. Tumor necrosis factor-α and interferon-γ synergistically activate the RANTES promoter through nuclear factor kB and interferon regulatory factor 1 (IRF-1) trancription factors. Biochemical Journal 356 (2000) 131-138
35. Linke A., Kuhn R., Muller W., Honarvar N., Li C., and Langhorne J. Plasmodium chabaudi: differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection. Experimental Parasitology 84 (1996) 253-263
36. Mills C.D. Molecular basis of "suppressor macrophages": arginine metabolism via nitric oxide synthetase pathway. The Journal of Immunology 146 (1991) 2719-2723
37. Neyer L.E., Grunig G., Fort M., Remington J.S., Rennick D., and Hunter C.A. Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii. Infection and Immunity 65 (1997) 1675-1682
38. Pfeffer K., Matsuyama T., Kundig T.M., Wakeham A., Kishihar K., Shahinian A., Weignmann K., Ohashi P.S., Kronke M., and Mak T.W. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73 (1993) 457-467
39. Sallusto F., Palermo B., Hoy A., and Lanzavechia A. The role of chemokine receptors in directing traffic of naive, type 1 and type 2 T cells. Current Topics in Microbiology Immunology 246 (1999) 123-128
40. Seabra S.H., de Souza W., and DaMatta R.A. Toxoplasma gondii partially inhibits nitric oxide production of activated murine macrophages. Experimental Parasitology 100 (2002) 62-70
41. Scharton-Kersten T., Yap G., Magram J., and Sher A. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. The Journal of Experimental Medicine 185 (1997) 1-13
42. Scharton-Kersten T.M., Wynn T.A., Denkers E.Y., Bala S., Showe L., Grunvald E., Hieny S., Gazzinelli R.T., and Sher A. In the absence of endogenous IFN-γ mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. The Journal of Immunology 157 (1996) 4045-4054
43. Sibley L.D., Adams L., and Fukutomi Y. Tumor necrosis factor-triggers antitoxoplasmal activity of IFN-primed macrophages. The Journal of Immunology 147 (1991) 2340-2345
44. Silva N.M., Tafuri W.L., Alvarez-Leite J.I., Mineo J.R., and Gazzinelli R.T. Toxoplasma gondii: the in vivo expression of BAG-5 and cyst formation is independent of TNF receptor and inducible nitric oxide synthase functions. Microbes and Infection 4 (2002) 261-270
45. Silva N.M., Rodrigues C.V., Santoro M.M., Reis L.F.L., Alvarez-Leite J.I., and Gazzinelli R.T. Expression of indoleamine 2,3-dioxygenase, tryptophan degradation and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous IFN-γ and requirement of IRF-1. Infection and Immunity 70 (2002) 859-868
46. Suzuki Y., Sher A., Yap G., Park D., Neyer L.E., Liesenfeld O., Fort M., Kang H., and Gufwoli E. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. The Journal of Immunology 164 (2000) 5375-5382
47. Suzuki Y., Orellana M.A., Schreiber R.D., and Remington J.S. Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science 240 (1988) 516-518
48. + immune T cells against toxoplasmosis in mice. The Journal of Immunology 140 (1988) 3943-3946
49. Taylor-Robinson A.W., Liew F.Y., Severn A., Xu D., McSorley S.J., Garside P., Padron J., and Phillips S. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. European Journal of Immunology 24 (1994) 980-984
50. Wei X.-Q., Charles I.G., Smith A., Ure J., Feng G.-J., Huang F.-P., Xu D., Muller W., Moncada S., and Liew F.Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375 (1995) 408-411
51. Welter A., Mineo J.R., Silva D.A.O., Lourenço E.V., Ferro E.A.V., Roque-Barreira M.C., and Silva N.M. BALB/c mice resistant to Toxoplasma gondii infection proved to be highly susceptible when previously infected with Myocoptes musculinus fur mites. International Journal of Experimental Pathology 88 (2007) 325-335
52. Williams M.S., Noguchi S., Henkart P.A., and Osawa Y. Nitric oxide synthase plays a signaling role in TCR-triggered apoptotic death. The Journal of Immunology 161 (1998) 6526-6531
53. Yap G.S., Scharton-Kersten T., Charest H., and Sher A. Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo. The Journal of Immunology 160 (1998) 1340-1345